SENSEX 77414.92 ▼ (0.25%)
BSE BANKEX 59542.38 ▲ (0.36%)

KIMIA BIOSCIENCES

BSE: 530313 22 Aug 2025
Healthcare
₹ 37.38
KIMIA BIOSCIENCES LIMITED specializes in Pharmaceuticals within the Healthcare sector.

KIMIA BIOSCIENCES - Share Price & Details

Market Cap
₹177.0
High /Low
86.8 / 35.1
Stock P/E
20.2
Book Value
₹1.68
Dividend Yield
0.0
ROCE
41.3
ROE
₹2,912
Face Value
1.0
PEG Ratio
0.31
EVEBITDA
₹9.93
Debt
33.9
CMP / FCF
26.3
Debt to equity
₹4.27
NP Ann
9.61
High price all time
86.8
Piotroski score
₹7.0
Graham Number
8.37
No. Eq. Shares
4.73
Net CF
₹0.06
Net profit
8.77
Price to book value
22.2
Interest Coverage
₹3.41
Low price all time
5.0
Industry PE
32.8
Reserves
₹3.22
Free Cash Flow
₹16.7

Price Chart


Volume Chart


Peer Comparison

Stock Total Income Net Profit Net Sales EPS Market Cap (in Cr) P/E
Shyama Computronics and Servic1.480.930.670.005.3335.5
Triochem Products Ltd.,3.25-4.52NA-18.440
KIMIA BIOSCIENCES LIMITED386.8619.92382.440.42177.020.2
TAKE SOLUTIONS LTD.108.7447.770.00.6717366.2
CORAL LABORATORIES LTD.306.1628.27281.357.911709.19

Peer Comparison Chart


About KIMIA BIOSCIENCES

KIMIA BIOSCIENCES LIMITED, with Security Code 530313, is a leading player in the Pharmaceuticals industry, categorized under the Healthcare sector, offering Equity instruments.


Latest News

Kimia Biosciences Reports Declining Financial Results Amid Rising Interest Costs in June 2025

(15 Aug 2025)
Kimia Biosciences has released its financial results for the quarter ending June 2025, revealing a decline in net sales to Rs 23.58 crore and a negative...
Read more →

Kimia Biosciences standalone net profit declines 58.33% in the June 2025 quarter

(14 Aug 2025)
Net profit of Kimia Biosciences declined 58.33% to Rs 0.60 crore in the quarter ended June 2025 as against Rs 1.44 crore during the previous quarter ended...
Read more →

What is the dividend policy of HOOK stock - Superior stock selection

(07 Aug 2025)
【Stock Buzz】✌️ Grow smarter with free access to high-growth picks and expert forecasts that often exceed 200% ROI.
Read more →

Kimia Biosciences Limited (530313) Gets Regulatory Approval - Build a portfolio that stands the test of time

(04 Aug 2025)
Kimia Biosciences Limited (530313) Gets Regulatory Approval ✌️【Stock Observations】✌️ Avoid costly mistakes and capitalize on proven...
Read more →

Kimia Biosciences Faces Mixed Technical Signals Amid Profit Growth and High Debt Concerns

(01 Aug 2025)
Kimia Biosciences has recently experienced an evaluation adjustment, influenced by its technical trends and mixed indicators.
Read more →

Kimia Biosciences Shows Strong Performance Amid High Debt Concerns and Valuation Challenges

(29 Jul 2025)
Kimia Biosciences has recently experienced a change in evaluation, reflecting a shift in its stock's technical landscape. The company has shown strong...
Read more →

Company Updates